← Back to headlines
Definium Therapeutics Reports Positive DT120 Depression Trial Data
Definium Therapeutics, Inc. (DFTX) has released positive data from its DT120 depression trial, potentially positioning its stock as a biotech opportunity.
15 Jul, 09:24 — 15 Jul, 09:24
Sources
Showing 1 of 1 sources
